4.7 Article

Key patient demographics shape innate immune topography in noncritical hypoxic COVID-19 pneumonia

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

Clinical Characteristics of Refractory Coronavirus Disease 2019 in Wuhan, China

Pingzheng Mo et al.

Summary: This study aimed to clarify the characteristics of patients with refractory COVID-19, finding that these patients were older, more likely to be male, and had more underlying comorbid conditions. Patients with refractory disease required more aggressive treatments such as oxygen therapy and mechanical ventilation.

CLINICAL INFECTIOUS DISEASES (2021)

Article Cardiac & Cardiovascular Systems

Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19 Results From the American Heart Association COVID-19 Cardiovascular Disease Registry

Nicholas S. Hendren et al.

Summary: This study found that obese patients are more likely to be hospitalized with COVID-19, and are at higher risk of in-hospital death or mechanical ventilation, particularly if young (age <= 50 years). Additionally, obese patients are also at higher risk for venous thromboembolism and dialysis. These observations support clear public health messaging and rigorous adherence to COVID-19 prevention strategies in all obese individuals regardless of age.

CIRCULATION (2021)

Article Multidisciplinary Sciences

Genetic mechanisms of critical illness in COVID-19

Erola Pairo-Castineira et al.

Summary: In critically ill patients with COVID-19, host genetic variants associated with antiviral defense mechanisms and inflammatory organ damage were identified through a genome-wide association study. These genetic signals provide potential targets for therapeutic development and repurposing of existing drugs. Large-scale randomized clinical trials will be essential to confirm the effectiveness of targeted treatment strategies.

NATURE (2021)

Article Multidisciplinary Sciences

Global absence and targeting of protective immune states in severe COVID-19

Alexis J. Combes et al.

Summary: Patients with mild COVID-19 exhibit a coordinated pattern of expression of interferon-stimulated genes (ISGs) across every cell population, whereas these ISG-expressing cells are systemically absent in patients with severe disease. Individuals with severe COVID-19 produce very high titres of anti-SARS-CoV-2 antibodies and have a lower viral load compared to individuals with mild disease.

NATURE (2021)

Article Medicine, General & Internal

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

A. C. Kalil et al.

Summary: Combination treatment with baricitinib plus remdesivir was superior to remdesivir alone in reducing recovery time and accelerating improvement in clinical status among patients with Covid-19, notably among those receiving high-flow oxygen or noninvasive ventilation. The combination was associated with fewer serious adverse events.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Biochemistry & Molecular Biology

COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas

Xianwen Ren et al.

Summary: The study revealed the presence of immune response dysfunction in COVID-19 patients, with different peripheral immune subtype changes associated with clinical features such as age, sex, severity, and disease stages. Additionally, dramatic transcriptomic changes were observed within virus-infected cells, and upregulation of S100A8/A9 in peripheral blood may contribute to the cytokine storms frequently observed in severe patients.
Article Multidisciplinary Sciences

Deciphering the state of immune silence in fatal COVID-19 patients

Pierre Bost et al.

Summary: COVID-19 patients show unique immune features, including lung accumulation of naive lymphoid cells, systemic expansion and activation of myeloid cells, and immune suppression. Loss of monocyte-driven and neutrophil-driven immune suppression may lead to fatal outcomes in severe patients. On the other hand, a lung CXCR6(+) effector memory T cell subset may be associated with better prognosis in severe COVID-19 patients.

NATURE COMMUNICATIONS (2021)

Editorial Material Immunology

Lack of Effectiveness of Repurposed Drugs for COVID-19 Treatment

Miguel Angel Martinez

FRONTIERS IN IMMUNOLOGY (2021)

Review Immunology

Equity in Vaccine Trials for Higher Weight People? A Rapid Review of Weight-Related Inclusion and Exclusion Criteria for COVID-19 Clinical Trials

Jessica Campbell et al.

Summary: It was found that higher weight individuals are significantly under-represented in most vaccine trials, which may result in reduced efficacy and acceptance of COVID-19 vaccines for this population group, exacerbating health inequities. Explicit inclusion of higher weight individuals in COVID-19 vaccine trials is necessary to reduce health inequities.

VACCINES (2021)

Article Multidisciplinary Sciences

Diverse functional autoantibodies in patients with COVID-19

Eric Y. Wang et al.

Summary: COVID-19 patients show increased autoantibody reactivities against immunomodulatory proteins, which may affect immune function and lead to different clinical outcomes.

NATURE (2021)

Editorial Material Pharmacology & Pharmacy

Development, evaluation and use of COVID-19 vaccines in older adults: Preliminary principles for the pandemic and beyond

Sarah N. Hilmer et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)

Article Biochemistry & Molecular Biology

The interferon landscape along the respiratory tract impacts the severity of COVID-19

Benedetta Sposito et al.

Summary: The study found that high levels of IFN-III, and to a lesser extent IFN-I, in the upper airways of COVID-19 patients with high viral burden indicate reduced disease risk or severity. Specific IFN-III members denote patients with a mild pathology and protect against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), while IFNs in the lower airways of patients with severe COVID-19 are associated with increased apoptosis and decreased proliferation. The data demonstrate a dynamic production of IFNs in SARS-CoV-2-infected patients and show opposing roles of IFNs at distinct anatomical sites.
Article Immunology

Baricitinib plus dexamethasone compared to dexamethasone for the treatment of severe COVID-19 pneumonia: A retrospective analysis

Eduardo Pérez-Alba et al.

JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2021)

Editorial Material Biochemistry & Molecular Biology

Calming the cytokine storm in COVID-19

Randy Q. Cron et al.

Summary: Cytokine blockade can improve the survival rate of COVID-19 patients at risk of respiratory failure, with timing and patient selection being crucial factors.

NATURE MEDICINE (2021)

Article Endocrinology & Metabolism

Associations between body-mass index and COVID-19 severity in 6.9 million people in England: a prospective, community-based, cohort study

Min Gao et al.

Summary: The study found that above a BMI of 23 kg/m(2), there is a linear increase in the risk of severe consequences of COVID-19 leading to hospital admission and death, and a linear increase in ICU admission risk across the entire BMI range. The impact of increasing BMI is particularly notable in individuals younger than 40 years and of Black ethnicity.

LANCET DIABETES & ENDOCRINOLOGY (2021)

Article Immunology

The Inhibitory Receptor CLEC12A Regulates PI3K-Akt Signaling to Inhibit Neutrophil Activation and Cytokine Release

Guillaume Pare et al.

Summary: CLEC12A modulates neutrophil activation and cytokine production through a specific signaling pathway, potentially serving as a therapeutic target for inflammatory diseases.

FRONTIERS IN IMMUNOLOGY (2021)

Article Multidisciplinary Sciences

Platelets amplify endotheliopathy in COVID-19

Tessa J. Barrett et al.

Summary: The study reveals an inflammatory hypercoagulable state between platelets and endothelial cells in COVID-19, with platelet-released factors promoting endotheliopathy. S100A8, S100A9, and their protein product MRP8/14 are enriched in COVID-19 platelets and contribute significantly to poor clinical outcomes. Targeting platelet P2Y(12) appears to be a promising strategy for reducing proinflammatory platelet-endothelial interactions in COVID-19.

SCIENCE ADVANCES (2021)

Article Multidisciplinary Sciences

Functional and genomic adaptations of blood monocytes to pregravid obesity during pregnancy

Suhas Sureshchandra et al.

Summary: Pregravid obesity is associated with adverse maternal health outcomes, with altered immunological state. Both lean and obese mothers showed elevated Th1 and Th2 cytokines during pregnancy, but obese subjects had dysregulated myeloid factors in circulation. Lean pregnancy was associated with enhanced immune response, while obese pregnancy showed signs of innate immune tolerance.

ISCIENCE (2021)

Review Biochemistry & Molecular Biology

Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies

Yu-Wen Zhou et al.

Summary: Due to limitations in current drug discovery efforts against SARS-CoV-2 and a lack of understanding of the biological mechanisms underlying COVID-19, alternative therapeutic targets are urgently needed. This study classified current COVID-19 therapeutic strategies into targeting the virus and targeting the host, focusing on repurposing drugs, emerging approaches, and promising potential targets.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Article Biochemistry & Molecular Biology

An immune-cell signature of bacterial sepsis

Miguel Reyes et al.

NATURE MEDICINE (2020)

Article Endocrinology & Metabolism

Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China

Qingxian Cai et al.

DIABETES CARE (2020)

Letter Medicine, General & Internal

Variation in COVID-19 Hospitalizations and Deaths Across New York City Boroughs

Rishi K. Wadhera et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Editorial Material Medicine, General & Internal

COVID-19 and Racial/Ethnic Disparities

Monica Webb Hooper et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Medicine, General & Internal

Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study

Tao Chen et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Article Medicine, General & Internal

Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization

Sara Y. Tartof et al.

ANNALS OF INTERNAL MEDICINE (2020)

Article Infectious Diseases

Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China

J. Zhang et al.

CLINICAL MICROBIOLOGY AND INFECTION (2020)

Article Hematology

Platelet gene expression and function in patients with COVID-19

Bhanu Kanth Manne et al.

Article Biochemistry & Molecular Biology

Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment

Jonas Schulte-Schrepping et al.

Article Biochemistry & Molecular Biology

Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19

Aymeric Silvin et al.

Editorial Material Medicine, Research & Experimental

Clinical trials for COVID-19 should include sex as a variable

Evelyne Bischof et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Medicine, Research & Experimental

Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent

Alessio Mazzoni et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Infectious Diseases

Estimates of the severity of coronavirus disease 2019: a model-based analysis

Robert Verity et al.

LANCET INFECTIOUS DISEASES (2020)

Article Multidisciplinary Sciences

Longitudinal analyses reveal immunological misfiring in severe COVID-19

Carolina Lucas et al.

NATURE (2020)

Article Biochemistry & Molecular Biology

A single-cell atlas of the peripheral immune response in patients with severe COVID-19

Aaron J. Wilk et al.

NATURE MEDICINE (2020)

Article Biochemistry & Molecular Biology

Age-dependent effects in the transmission and control of COVID-19 epidemics

Nicholas G. Davies et al.

NATURE MEDICINE (2020)

Article Cardiac & Cardiovascular Systems

Platelets Can Associate With SARS-CoV-2 RNA and Are Hyperactivated in COVID-19

Younes Zaid et al.

CIRCULATION RESEARCH (2020)

Article Multidisciplinary Sciences

Sex differences in immune responses that underlie COVID-19 disease outcomes

Takehiro Takahashi et al.

NATURE (2020)

Article Biochemistry & Molecular Biology

A dynamic COVID-19 immune signature includes associations with poor prognosis

Adam G. Laing et al.

NATURE MEDICINE (2020)

Article Multidisciplinary Sciences

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Qian Zhang et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Paul Bastard et al.

SCIENCE (2020)

Article Medicine, Research & Experimental

Baricitinib restrains the immune dysregulation in patients with severe COVID-19

Vincenzo Bronte et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Endocrinology & Metabolism

BMI and future risk for COVID-19 infection and death across sex, age and ethnicity: Preliminary findings from UK biobank

Naveed Sattar et al.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)

Article Multidisciplinary Sciences

The uric acid crystal receptor Clec12A potentiates type I interferon responses

Kai Li et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Biochemical Research Methods

Fast, sensitive and accurate integration of single-cell data with Harmony

Ilya Korsunsky et al.

NATURE METHODS (2019)

Article Biochemistry & Molecular Biology

A mitochondrial specific stress response in mammalian cells

Q Zhao et al.

EMBO JOURNAL (2002)